Literature DB >> 23583105

Modeling autism by SHANK gene mutations in mice.

Yong-Hui Jiang1, Michael D Ehlers.   

Abstract

Shank family proteins (Shank1, Shank2, and Shank3) are synaptic scaffolding proteins that organize an extensive protein complex at the postsynaptic density (PSD) of excitatory glutamatergic synapses. Recent human genetic studies indicate that SHANK family genes (SHANK1, SHANK2, and SHANK3) are causative genes for idiopathic autism spectrum disorders (ASD). Neurobiological studies of Shank mutations in mice support a general hypothesis of synaptic dysfunction in the pathophysiology of ASD. However, the molecular diversity of SHANK family gene products, as well as the heterogeneity in human and mouse phenotypes, pose challenges to modeling human SHANK mutations. Here, we review the molecular genetics of SHANK mutations in human ASD and discuss recent findings where such mutations have been modeled in mice. Conserved features of synaptic dysfunction and corresponding behaviors in Shank mouse mutants may help dissect the pathophysiology of ASD, but also highlight divergent phenotypes that arise from different mutations in the same gene.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23583105      PMCID: PMC3659167          DOI: 10.1016/j.neuron.2013.03.016

Source DB:  PubMed          Journal:  Neuron        ISSN: 0896-6273            Impact factor:   17.173


  127 in total

Review 1.  Synapse structure: glutamate receptors connected by the shanks.

Authors:  M D Ehlers
Journal:  Curr Biol       Date:  1999-11-18       Impact factor: 10.834

2.  Expression of postsynaptic density proteins of the ProSAP/Shank family in the thymus.

Authors:  Peter Redecker; Jürgen Bockmann; Tobias M Böckers
Journal:  Histochem Cell Biol       Date:  2006-06-07       Impact factor: 4.304

Review 3.  Etiological heterogeneity in autism spectrum disorders: more than 100 genetic and genomic disorders and still counting.

Authors:  Catalina Betancur
Journal:  Brain Res       Date:  2010-12-01       Impact factor: 3.252

4.  The autism diagnostic observation schedule-generic: a standard measure of social and communication deficits associated with the spectrum of autism.

Authors:  C Lord; S Risi; L Lambrecht; E H Cook; B L Leventhal; P C DiLavore; A Pickles; M Rutter
Journal:  J Autism Dev Disord       Date:  2000-06

5.  SHANK1 Deletions in Males with Autism Spectrum Disorder.

Authors:  Daisuke Sato; Anath C Lionel; Claire S Leblond; Aparna Prasad; Dalila Pinto; Susan Walker; Irene O'Connor; Carolyn Russell; Irene E Drmic; Fadi F Hamdan; Jacques L Michaud; Volker Endris; Ralph Roeth; Richard Delorme; Guillaume Huguet; Marion Leboyer; Maria Rastam; Christopher Gillberg; Mark Lathrop; Dimitri J Stavropoulos; Evdokia Anagnostou; Rosanna Weksberg; Eric Fombonne; Lonnie Zwaigenbaum; Bridget A Fernandez; Wendy Roberts; Gudrun A Rappold; Christian R Marshall; Thomas Bourgeron; Peter Szatmari; Stephen W Scherer
Journal:  Am J Hum Genet       Date:  2012-04-12       Impact factor: 11.025

Review 6.  Behavioural phenotyping assays for mouse models of autism.

Authors:  Jill L Silverman; Mu Yang; Catherine Lord; Jacqueline N Crawley
Journal:  Nat Rev Neurosci       Date:  2010-07       Impact factor: 34.870

Review 7.  Ultrasonic vocalizations: a tool for behavioural phenotyping of mouse models of neurodevelopmental disorders.

Authors:  Maria Luisa Scattoni; Jacqueline Crawley; Laura Ricceri
Journal:  Neurosci Biobehav Rev       Date:  2008-08-13       Impact factor: 8.989

8.  Shank3 mutant mice display autistic-like behaviours and striatal dysfunction.

Authors:  João Peça; Cátia Feliciano; Jonathan T Ting; Wenting Wang; Michael F Wells; Talaignair N Venkatraman; Christopher D Lascola; Zhanyan Fu; Guoping Feng
Journal:  Nature       Date:  2011-03-20       Impact factor: 49.962

9.  High proportion of 22q13 deletions and SHANK3 mutations in Chinese patients with intellectual disability.

Authors:  Xiaohong Gong; Yu-Wu Jiang; Xin Zhang; Yu An; Jun Zhang; Ye Wu; Jingmin Wang; Yangfei Sun; Yanyan Liu; Xuewu Gao; Yiping Shen; Xiru Wu; Zilong Qiu; Li Jin; Bai-Lin Wu; Hongyan Wang
Journal:  PLoS One       Date:  2012-04-11       Impact factor: 3.240

10.  Exome sequencing in sporadic autism spectrum disorders identifies severe de novo mutations.

Authors:  Brian J O'Roak; Pelagia Deriziotis; Choli Lee; Laura Vives; Jerrod J Schwartz; Santhosh Girirajan; Emre Karakoc; Alexandra P Mackenzie; Sarah B Ng; Carl Baker; Mark J Rieder; Deborah A Nickerson; Raphael Bernier; Simon E Fisher; Jay Shendure; Evan E Eichler
Journal:  Nat Genet       Date:  2011-05-15       Impact factor: 38.330

View more
  210 in total

Review 1.  Excitatory/Inhibitory Balance and Circuit Homeostasis in Autism Spectrum Disorders.

Authors:  Sacha B Nelson; Vera Valakh
Journal:  Neuron       Date:  2015-08-19       Impact factor: 17.173

2.  Epigenetic dysregulation of SHANK3 in brain tissues from individuals with autism spectrum disorders.

Authors:  Li Zhu; Xiaoming Wang; Xin-Lei Li; Aaron Towers; Xinyu Cao; Ping Wang; Rachel Bowman; Hyuna Yang; Jennifer Goldstein; Yi-Ju Li; Yong-Hui Jiang
Journal:  Hum Mol Genet       Date:  2013-11-01       Impact factor: 6.150

3.  Acute and crucial requirement for MeCP2 function upon transition from early to late adult stages of brain maturation.

Authors:  Fang Du; Minh Vu Chuong Nguyen; Ariel Karten; Christy A Felice; Gail Mandel; Nurit Ballas
Journal:  Hum Mol Genet       Date:  2016-02-16       Impact factor: 6.150

Review 4.  Emerging Themes in PDZ Domain Signaling: Structure, Function, and Inhibition.

Authors:  Xu Liu; Ernesto J Fuentes
Journal:  Int Rev Cell Mol Biol       Date:  2018-06-28       Impact factor: 6.813

5.  Altered neurogenesis and disrupted expression of synaptic proteins in prefrontal cortex of SHANK3-deficient non-human primate.

Authors:  Hui Zhao; Zhuchi Tu; Huijuan Xu; Sen Yan; Huanhuan Yan; Yinghui Zheng; Weili Yang; Jiezhao Zheng; Zhujun Li; Rui Tian; Youming Lu; Xiangyu Guo; Yong-Hui Jiang; Xiao-Jiang Li; Yong Q Zhang
Journal:  Cell Res       Date:  2017-07-25       Impact factor: 25.617

6.  Alleviation of N-Methyl-D-Aspartate Receptor-Dependent Long-Term Depression via Regulation of the Glycogen Synthase Kinase-3β Pathway in the Amygdala of a Valproic Acid-Induced Animal Model of Autism.

Authors:  Han-Fang Wu; Po See Chen; Yi-Ju Chen; Chi-Wei Lee; I-Tuan Chen; Hui-Ching Lin
Journal:  Mol Neurobiol       Date:  2016-08-30       Impact factor: 5.590

7.  TAR DNA-Binding Protein 43 and Disrupted in Schizophrenia 1 Coaggregation Disrupts Dendritic Local Translation and Mental Function in Frontotemporal Lobar Degeneration.

Authors:  Ryo Endo; Noriko Takashima; Yoko Nekooki-Machida; Yusuke Komi; Kelvin Kai-Wan Hui; Masaki Takao; Hiroyasu Akatsu; Shigeo Murayama; Akira Sawa; Motomasa Tanaka
Journal:  Biol Psychiatry       Date:  2018-03-29       Impact factor: 13.382

Review 8.  Advancing the discovery of medications for autism spectrum disorder using new technologies to reveal social brain circuitry in rodents.

Authors:  Martien J Kas; Meera E Modi; Michael D Saxe; Daniel G Smith
Journal:  Psychopharmacology (Berl)       Date:  2014-02-13       Impact factor: 4.530

Review 9.  Pre-clinical models of neurodevelopmental disorders: focus on the cerebellum.

Authors:  Alexey V Shevelkin; Chinezimuzo Ihenatu; Mikhail V Pletnikov
Journal:  Rev Neurosci       Date:  2014       Impact factor: 4.353

10.  The Neurobiological Basis for Social Affiliation in Autism Spectrum Disorder and Schizophrenia.

Authors:  Amanda Crider; Anilkumar Pillai
Journal:  Curr Behav Neurosci Rep       Date:  2016-04-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.